Biora Therapeutics, Inc. – NASDAQ:BIOR

Biora Therapeutics stock price today

$0.22
-0.22
-50.01%
Financial Health
0
1
2
3
4
5
6
7
8
9

Biora Therapeutics stock price monthly change

-35.05%
month

Biora Therapeutics stock price quarterly change

-35.05%
quarter

Biora Therapeutics stock price yearly change

-66.92%
year

Biora Therapeutics key metrics

Market Cap
2.03M
Enterprise value
117.02M
P/E
-0.42
EV/Sales
198.00
EV/EBITDA
-1.67
Price/Sales
33.33
Price/Book
-0.19
PEG ratio
N/A
EPS
-7.11
Revenue
N/A
EBITDA
-66.83M
Income
-110.86M
Revenue Q/Q
27000%
Revenue Y/Y
608%
Profit margin
-14790.86%
Oper. margin
-18029.1%
Gross margin
30.8%
EBIT margin
-18029.1%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Biora Therapeutics stock price history

Biora Therapeutics stock forecast

Biora Therapeutics financial statements

Biora Therapeutics, Inc. (NASDAQ:BIOR): Profit margin
Jun 2023 2K -17.80M -890350%
Sep 2023 0 -73.45M
Dec 2023 872K -15.41M -1767.55%
Mar 2024 542K -4.18M -772.88%
Biora Therapeutics, Inc. (NASDAQ:BIOR): Analyst Estimates
2025 2.50M -75.53M -3018.48%
2026 2.76M -81.07M -2934.75%
2027 6.1M -20.50M -336.15%
2028 20.6M -17.82M -86.52%
  • Analysts Price target

  • Financials & Ratios estimates

0%
Yield TTM
Biora Therapeutics, Inc. (NASDAQ:BIOR): Payout ratio
Payout ratio 0%
Biora Therapeutics, Inc. (NASDAQ:BIOR): Dividend Yield
2019 0.07%
2020
2021
2022
2023
Biora Therapeutics, Inc. (NASDAQ:BIOR): Debt to assets
Jun 2023 49673000 170.55M 343.35%
Sep 2023 34703000 153.48M 442.29%
Dec 2023 31215000 132.63M 424.91%
Mar 2024 22990000 123.17M 535.78%
Biora Therapeutics, Inc. (NASDAQ:BIOR): Cash Flow
Jun 2023 -11.62M -19K 7.63M
Sep 2023 -11.03M -1K -2.84M
Dec 2023 -13.74M 2.46M 13.91M
Mar 2024 -12.49M 3.00M 5.1M

Biora Therapeutics alternative data

Biora Therapeutics, Inc. (NASDAQ:BIOR): Employee count
Aug 2023 54
Sep 2023 54
Oct 2023 54
Nov 2023 54
Dec 2023 54
Jan 2024 54
Feb 2024 54
Mar 2024 54
Apr 2024 54
May 2024 58
Jun 2024 58
Jul 2024 58

Biora Therapeutics other data

96.99% +61.78%
of BIOR is owned by hedge funds
296.22K -2.33M
shares is hold by hedge funds

Biora Therapeutics, Inc. (NASDAQ:BIOR): Insider trades (number of shares)
Period Buy Sel
Jul 2022 0 7517
Nov 2022 25012500 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
ATHYRIUM OPPORTUNITIES III CO-INVEST 1 LP 10 percent owner
Warrant 12,506,250 $0.33 $4,127,063
Purchase
ATHYRIUM OPPORTUNITIES III CO-INVEST 1 LP 10 percent owner
Common Stock 12,506,250 N/A N/A
Sale
SARNA SURBHI director
Common Stock 7,517 $0.61 $4,585
Thursday, 14 November 2024
globenewswire.com
Thursday, 7 November 2024
globenewswire.com
Tuesday, 29 October 2024
globenewswire.com
Monday, 28 October 2024
globenewswire.com
Monday, 26 August 2024
globenewswire.com
Monday, 12 August 2024
seekingalpha.com
globenewswire.com
globenewswire.com
Thursday, 8 August 2024
globenewswire.com
Tuesday, 11 June 2024
globenewswire.com
Monday, 20 May 2024
globenewswire.com
Wednesday, 15 May 2024
seekingalpha.com
globenewswire.com
Tuesday, 7 May 2024
globenewswire.com
Monday, 6 May 2024
globenewswire.com
Tuesday, 30 April 2024
globenewswire.com
Monday, 8 April 2024
globenewswire.com
Thursday, 4 April 2024
globenewswire.com
Wednesday, 3 April 2024
globenewswire.com
Monday, 1 April 2024
globenewswire.com
Tuesday, 26 March 2024
Seeking Alpha
Monday, 18 March 2024
GlobeNewsWire
Monday, 13 November 2023
Seeking Alpha
Monday, 6 November 2023
GlobeNewsWire
Friday, 22 September 2023
InvestorPlace
Monday, 11 September 2023
GlobeNewsWire
Monday, 14 August 2023
Seeking Alpha
Saturday, 15 July 2023
GlobeNewsWire
Thursday, 8 June 2023
GlobeNewsWire
Wednesday, 24 May 2023
InvestorPlace
  • What's the price of Biora Therapeutics stock today?

    One share of Biora Therapeutics stock can currently be purchased for approximately $0.22.

  • When is Biora Therapeutics's next earnings date?

    Unfortunately, Biora Therapeutics's (BIOR) next earnings date is currently unknown.

  • Does Biora Therapeutics pay dividends?

    No, Biora Therapeutics does not pay dividends.

  • How much money does Biora Therapeutics make?

    Biora Therapeutics has a market capitalization of 2.03M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 98.69% to 4K US dollars.

  • What is Biora Therapeutics's stock symbol?

    Biora Therapeutics, Inc. is traded on the NASDAQ under the ticker symbol "BIOR".

  • What is Biora Therapeutics's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Biora Therapeutics?

    Shares of Biora Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Biora Therapeutics have?

    As Jul 2024, Biora Therapeutics employs 58 workers, which is 7% more then previous quarter.

  • When Biora Therapeutics went public?

    Biora Therapeutics, Inc. is publicly traded company for more then 5 years since IPO on 19 Jun 2020.

  • What is Biora Therapeutics's official website?

    The official website for Biora Therapeutics is bioratherapeutics.com.

  • Where are Biora Therapeutics's headquarters?

    Biora Therapeutics is headquartered at 4330 La Jolla Village Drive, San Diego, CA.

  • How can i contact Biora Therapeutics?

    Biora Therapeutics's mailing address is 4330 La Jolla Village Drive, San Diego, CA and company can be reached via phone at +855 2932639.

Biora Therapeutics company profile:

Biora Therapeutics, Inc.

bioratherapeutics.com
Exchange:

NASDAQ

Full time employees:

58

Industry:

Biotechnology

Sector:

Healthcare

Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ingestible capsule for needle-free delivery of biotherapeutics directly into the intestinal mucosa for enhanced systemic uptake. It is also developing diagnostics devices to help characterize the GI tract and diagnose GI diseases, such as small intestine bacterial overgrowth through the development of various technologies to diagnose at the site of the disease. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California.

4330 La Jolla Village Drive
San Diego, CA 92122

CIK: 0001580063
ISIN: US74319F3055
CUSIP: 74319F107